Cargando…

Cognition in multiple sclerosis: State of the field and priorities for the future

Cognitive decline is recognized as a prevalent and debilitating symptom of multiple sclerosis (MS), especially deficits in episodic memory and processing speed. The field aims to (1) incorporate cognitive assessment into standard clinical care and clinical trials, (2) utilize state-of-the-art neuroi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sumowski, James F., Benedict, Ralph, Enzinger, Christian, Filippi, Massimo, Geurts, Jeroen J., Hamalainen, Paivi, Hulst, Hanneke, Inglese, Matilde, Leavitt, Victoria M., Rocca, Maria A., Rosti-Otajarvi, Eija M., Rao, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Views & Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818015/ https://www.ncbi.nlm.nih.gov/pubmed/29343470 http://dx.doi.org/10.1212/WNL.0000000000004977

Ejemplares similares

Validity and reliability of the Finnish version of the Multiple Sclerosis Impact Scale‐29
por: Rosti‐Otajärvi, Eija, et al.
Publicado: (2017)

Validity and reliability of the Fatigue Severity Scale in Finnish multiple sclerosis patients
por: Rosti‐Otajärvi, Eija, et al.
Publicado: (2017)

Gray matter imaging in multiple sclerosis: what have we learned?
por: Hulst, Hanneke E, et al.
Publicado: (2011)

Executive Functions May Predict Outcome in Deep Brain Stimulation of Anterior Nucleus of Thalamus for Treatment of Refractory Epilepsy
por: Järvenpää, Soila, et al.
Publicado: (2018)

Priority of discovery in the life sciences
por: Vale, Ronald D, et al.
Publicado: (2016)

Defining the clinical course of multiple sclerosis: The 2013 revisions
por: Lublin, Fred D., et al.
Publicado: (2014)

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective
por: Rocca, Maria A., et al.
Publicado: (2022)

The importance of hippocampal dynamic connectivity in explaining memory function in multiple sclerosis
por: van Geest, Quinten, et al.
Publicado: (2018)

Towards digital healthy ageing: the case of Agatha and priorities moving forward
por: Gariboldi, Maria Isabella, et al.
Publicado: (2023)

Two disciplines, one priority: the seamless integration of human and veterinary microbiology is urgent
por: Howard, Colin R
Publicado: (2012)

Artificial double inversion recovery images for (juxta)cortical lesion visualization in multiple sclerosis
por: Bouman, Piet M, et al.
Publicado: (2021)

Higher Education Moderates the Effect of T2 Lesion Load and Third Ventricle Width on Cognition in Multiple Sclerosis
por: Pinter, Daniela, et al.
Publicado: (2014)

Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis
por: Sumowski, James F.
Publicado: (2015)

Preclinical testing of antimicrobials for cystic fibrosis lung infections: current needs and future priorities
por: Hubert, Lucile, et al.
Publicado: (2023)

Non-invasive respiratory support in the management of acute COVID-19 pneumonia: considerations for clinical practice and priorities for research
por: Weerakkody, Sampath, et al.
Publicado: (2022)

Quantitative magnetic resonance imaging towards clinical application in multiple sclerosis
por: Granziera, Cristina, et al.
Publicado: (2021)

Infectious causes of multiple sclerosis
por: Gilden, Donald H
Publicado: (2005)

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Is MS affecting the CNS only?: Lessons from clinic to myelin pathophysiology
por: Oudejans, Ellen, et al.
Publicado: (2020)

Cognitive functioning in everyday life: The development of a questionnaire on instrumental activities of daily living in multiple sclerosis
por: van Dam, Maureen, et al.
Publicado: (2021)

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Towards an understating of signal transduction protein interaction networks
por: Kaladhar, Dowluru SVGK, et al.
Publicado: (2012)

Recommendations for observational studies of comorbidity in multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

The challenge of comorbidity in clinical trials for multiple sclerosis
por: Marrie, Ruth Ann, et al.
Publicado: (2016)

Visibility and representation of women in multiple sclerosis research
por: Thomson, Alison, et al.
Publicado: (2019)

Cognitive impairment in multiple sclerosis: clinical management, MRI, and therapeutic avenues
por: Benedict, Ralph H B, et al.
Publicado: (2020)

Feasibility of cognitive rehabilitation in patients with advanced multiple sclerosis: A pilot study
por: Prouskas, Stefanos E, et al.
Publicado: (2021)

Improving quality, affordability, and equity of multiple sclerosis care
por: Langer‐Gould, Annette, et al.
Publicado: (2021)

The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis
por: Rocca, Maria A., et al.
Publicado: (2017)

Nogo-A and Nogo-66 receptor in amyotrophic lateral sclerosis
por: Teng, Felicia Yu Hsuan, et al.
Publicado: (2008)

Nonconventional MRI biomarkers for in vivo monitoring of pathogenesis in multiple sclerosis
por: Londoño, Ana C., et al.
Publicado: (2014)

Can We Treat Secondary Progressive Multiple Sclerosis Now?
por: Bhatia, Rohit, et al.
Publicado: (2019)

Serum neurofilament light as a biomarker in progressive multiple sclerosis
por: Kapoor, Raju, et al.
Publicado: (2020)

The 2013 clinical course descriptors for multiple sclerosis: A clarification
por: Lublin, Fred D., et al.
Publicado: (2020)

Monitoring Progressive Multiple Sclerosis with Novel Imaging Techniques
por: Petracca, Maria, et al.
Publicado: (2018)

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Chronic cerebrospinal venous insufficiency in Multiple Sclerosis: A note for caution
por: Bhatia, Rohit, et al.
Publicado: (2012)

The topographical model of multiple sclerosis: A dynamic visualization of disease course
por: Krieger, Stephen C., et al.
Publicado: (2016)

Could Conservative Iron Chelation Lead to Neuroprotection in Amyotrophic Lateral Sclerosis?
por: Moreau, Caroline, et al.
Publicado: (2018)

No Evidence of Disease Activity (NEDA) in Multiple Sclerosis - Shifting the Goal Posts
por: Pandit, Lekha
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_mv8o81jqkpv0dvgdu0ntcrtj54